Nicholas D. Kindon

ORCID: 0009-0002-2862-052X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Adenosine and Purinergic Signaling
  • Synthetic Organic Chemistry Methods
  • Receptor Mechanisms and Signaling
  • Asymmetric Synthesis and Catalysis
  • Pharmacological Receptor Mechanisms and Effects
  • Coordination Chemistry and Organometallics
  • Chemokine receptors and signaling
  • Chemical Synthesis and Analysis
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • interferon and immune responses
  • Analytical Chemistry and Chromatography
  • Immunotherapy and Immune Responses
  • Synthesis of heterocyclic compounds
  • Monoclonal and Polyclonal Antibodies Research
  • GABA and Rice Research
  • Neuroscience and Neuropharmacology Research
  • Synthesis and Biological Evaluation
  • Fluorine in Organic Chemistry
  • Mesoporous Materials and Catalysis
  • Electroconvulsive Therapy Studies
  • Cannabis and Cannabinoid Research
  • Neuropeptides and Animal Physiology
  • Multicomponent Synthesis of Heterocycles
  • Sphingolipid Metabolism and Signaling

University of Nottingham
2016-2024

University of Birmingham
2019-2024

Loughborough University
1996-2017

AstraZeneca (United Kingdom)
2001-2017

University of Oxford
2004-2009

University of Cambridge
1988-1996

Research & Development Institute
1995

University of Wisconsin–Madison
1990

The platelet P2T receptor plays a major role in aggregation, and its antagonists are predicted to have significant therapeutic potential as antithrombotic agents. We explored analogues of adenosine triphosphate (ATP), which is weak, nonselective but competitive antagonist. Modification the polyphosphate side chain prevent breakdown agonist diphosphate (ADP) substitution adenine moiety enhance affinity selectivity for led identification 10e (AR-C67085MX), having an IC50 2.5 nM against...

10.1021/jm981072s article EN Journal of Medicinal Chemistry 1999-01-01

CXCL17 is a chemokine principally expressed by mucosal tissues, where it facilitates chemotaxis of monocytes, dendritic cells, and macrophages has antimicrobial properties. also implicated in the pathology inflammatory disorders progression several cancers, its expression increased during viral infections lung. However, exact role health disease requires further investigation, there need for confirmed molecular targets mediating functional responses. Using range bioluminescence resonance...

10.1126/scisignal.abl3758 article EN Science Signaling 2024-03-19

Abstract To study the localisation of G protein-coupled receptors (GPCR) in their native cellular environment requires visualisation through fluorescent labelling. overcome requirement for genetic modification receptor or limitations dissociable ligands, here we describe rational design a compound that covalently and selectively labels GPCR living cells with moiety. We designed antagonist, which linker incorporated between pharmacophore (ZM241385) fluorophore (sulfo-cyanine5) is able to...

10.1038/s42003-020-01451-w article EN cc-by Communications Biology 2020-11-27

The study of protein function and dynamics in their native cellular environment is essential for progressing fundamental science. To overcome the requirement genetic modification or limitations dissociable fluorescent ligands, ligand-directed (LD) chemistry has most recently emerged as a complementary, bioorthogonal approach labeling proteins. Here, we describe rational design, development, application first A1AR living cells. We pharmacologically demonstrate covalent expressed cells while...

10.1021/acs.jmedchem.4c00835 article EN cc-by Journal of Medicinal Chemistry 2024-07-12

Among class A G protein-coupled receptors (GPCR), the human adenosine A2A receptor (hA2AAR) remains an attractive drug target. However, translation of A2AAR ligands into clinic has proved challenging and improved understanding pharmacology could promote development more efficacious therapies. Subtype-selective fluorescent probes would allow detailed real-time pharmacological investigations both in vitro vivo. In present study, two families were designed around known hA2AAR selective...

10.1021/acs.jmedchem.9b01856 article EN cc-by Journal of Medicinal Chemistry 2019-12-30

The C–X–C chemokine receptor type 4, or CXCR4, is a found to promote cancer progression and metastasis of various cell types. To investigate the pharmacology this receptor, further elucidate its role in cancer, novel chemical tools are necessity. In present study, using classic medicinal chemistry approaches, small-molecule-based fluorescent probes were designed synthesized based on previously reported small-molecule antagonists. Here, we report development three distinct classes that show...

10.1021/acs.jmedchem.3c00151 article EN cc-by Journal of Medicinal Chemistry 2023-03-21

Reaction of hindered lithium amides with readily available (enantiopure) terminal epoxides gives 2-ene-1,4-diols via carbenoid dimerization the corresponding α-lithiated epoxides. d-Mannitol and d-iditol were synthesized using this method in three steps from (S)-tritylglycidyl ether.

10.1021/ol050402h article EN Organic Letters 2005-05-10

A new reactivity mode of lithium amides with epoxides leads to hindered enamines. The reaction some these enamines unactivated primary and secondary alkyl halides is described, which expands the range electrophiles that one can use in synthesis mono-alkylated aldehydes.

10.1021/ja031770o article EN Journal of the American Chemical Society 2004-05-12

In vitro synthesis of the iron-molybdenum cofactor (FeMo-co) dinitrogenase using homocitrate and its analogs allows formation modified forms FeMo-co that show altered substrate specificities (N2, acetylene, cyanide, or proton reduction) nitrogenase [reduced ferredoxin:dinitrogen oxidoreductase (ATP-hydrolyzing), EC 1.18.6.1]. The (1R,2S)-threo- (1S,2S)-erythro-fluorinated diastereomers have been incorporated in into place homocitrate. Dinitrogenase activated with synthesized...

10.1073/pnas.87.17.6517 article EN Proceedings of the National Academy of Sciences 1990-09-01

1. The role of endogenous ADP in platelet aggregation vivo remains unclear due to the lack suitable P2T-antagonist probes. This paper describes potency, selectivity and specificity novel P 2T-purinoceptor antagonist, FPL 67085 (2-propylthio-D-beta,gamma-dichloromethylene ATP) both vitro anaesthetized rat vivo. 2. (3-30 nM) produced concentration-dependent rightward displacement concentration-effect (E/[A]) curve for ADP-induced human washed platelets with no effect on ADP-independent at < or...

10.1111/j.1476-5381.1995.tb15925.x article EN British Journal of Pharmacology 1995-07-01

The conjugate addition of the phenyldimethylsilyl-cuprate reagent to cinnamate and crotonate esters amides various known chiral auxilaries is diastereoselective, making available β-silylesters high enantiomeric excess; sense diastereoselectivity anomalously different from established precedent in case silyl-cuprate ester (1, R = Ph, R*=d).

10.1039/c39870001177 article EN Journal of the Chemical Society Chemical Communications 1987-01-01

A new reactivity mode of hindered lithium amides with terminal epoxides is described whereby aldehyde enamines are produced via a previously unrecognized reaction pathway. Some these display unprecedented C-alkylation toward unactivated primary and secondary alkyl halides. For comparison, the synthesized traditional condensation method was examined. C- rather than N-alkylation dominant pathway found range electrophiles, making this route to α-alkylated aldehydes more synthetically useful reported.

10.1021/jo802016t article EN The Journal of Organic Chemistry 2008-12-23

N-(5-Bromo-3-methoxypyrazin-2-yl)-5-chlorothiophene-2-sulfonamide 1 was identified as a hit in CCR4 receptor antagonist high-throughput screen (HTS) of subset the AstraZeneca compound bank. As with lead-like profile, it an excellent starting point for program and enabled rapid progression through Lead Identification Optimization phases resulting discovery two bioavailable candidate drugs.

10.1021/acsmedchemlett.7b00315 article EN ACS Medicinal Chemistry Letters 2017-09-01

The human P2Y2 receptor (hP2Y2R) is a G-protein-coupled that shows promise as therapeutic target for many important conditions, including antimetastatic cancer and more recently idiopathic pulmonary fibrosis. As such, there need new hP2Y2R antagonists molecular probes to study this receptor. Herein, we report the development of series non-nucleotide antagonists, based on known, antagonist AR-C118925 (1), leading discovery fluorescent ligands containing different linkers fluorophores. One...

10.1021/acs.jmedchem.8b00139 article EN cc-by Journal of Medicinal Chemistry 2018-03-20

The adenosine A1 receptor (A1AR) is a G-protein-coupled (GPCR) that provides important therapeutic opportunities for number of conditions including congestive heart failure, tachycardia, and neuropathic pain. development A1AR-selective fluorescent ligands will enhance our understanding the subcellular mechanisms underlying A1AR pharmacology facilitating more efficacious selective therapies. Herein, we report design, synthesis, application novel series probes based on 8-functionalized...

10.1021/acs.jmedchem.0c02067 article EN cc-by-nc-nd Journal of Medicinal Chemistry 2021-03-16

The conjugate addition of the phenyldimethylsilyl-cuprate reagent to cinnamate and crotonate esters amides 1 various known chiral auxiliaries, a–e, is diastereoselective. sense diastereoselectivity silyl-cuprate 1b–d, 8 9 different from established precedent based on carbon-cuprates, but normal for amide 1a, imides 1e 21, oxazolidine 6. auxiliary e gives best results those tested, silicon-containing group can be removed using alkoxide ion in aprotic media, making available β-silyl 27–29 high...

10.1039/p19950000303 article EN Journal of the Chemical Society. Perkin transactions I/Journal of the Chemical Society. Perkin transactions. I 1995-01-01

A novel molecular scaffold has been synthesized, and its incorporation into new analogues of biologically active molecules across multiple target classes will be discussed. In these studies, we have shown use the tricyclic to synthesize potent inhibitors serine peptidase DPP-4, antagonists CCR5 receptor, highly selective PI3K δ isoform inhibitors. We also describe predicted physicochemical properties resulting conclude that tractable could potential application in future drug discovery programs.

10.1021/acs.jmedchem.6b01801 article EN publisher-specific-oa Journal of Medicinal Chemistry 2017-01-27

The homochiral pentadienylsilanes (3Z,5E)-(hepta-3,5-dien-2-yl)dimethyl(phenyl)silane 9, (3Z,5E)-(hepta-3,5-dien-2-yl)trimethylsilane 13, (4Z,6E)-(2-methylocta-4,6-dien-3-yl)dimethyl(phenyl)silane 14 and (4Z,6E)-(2-methylocata-4,6-dien-3-yl)trimethylsilane 17 undergo Lewis acid catalysed reactions with isobutyraldehyde its dimethyl acetal stereospecifically anti surprisingly high levels of stereoselectivity, ca. 90:10. (3Z)-hexa-3,5-dien-2-yldimethyl(phenyl)silane 20aa,...

10.1039/p19960001171 article EN Journal of the Chemical Society. Perkin transactions I/Journal of the Chemical Society. Perkin transactions. I 1996-01-01
Coming Soon ...